CVE-2026-75109: determined · Missing Authorization
Affects determinedSource CVE Database V5
Not known to be exploited · CVSS 7.1 High.
Data as of 16 Nov 2026, 20:25 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 22% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:H/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 17 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| determined-aidetermined | Affected
| Fixed in– |
GitHubdeterminedpkg:github/determinedOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Until a fix is available, restrict access to the API endpoints to trusted users only and monitor for suspicious task control activity.
Description
Determined fails to authorize requests on the generic task kill, pause, and unpause endpoints in the API handlers. Authenticated attackers can disrupt other users' workloads by terminating, pausing, or unpausing tasks they do not own.
References
- github.com/determined-ai/determined/issues/10270 (opens in a new tab)
- github.com/determined-ai/determined (opens in a new tab)
- github.com/determined-ai/determined/blob/main/master/internal/api_generic_tasks.go (opens in a new tab)
- vulncheck.com/advisories/determined-missing-authorization-check-on-generic-task-endpoints (opens in a new tab)